Advancing Blood Disorder Treatments Through Precision Therapeutics
This episode features Drs. Terri Parker and Peter Lenting discussing advancements in blood disorder treatments. Dr. Lenting shares insights on a new bispecific antibody for von Willebrand disease, while Dr. Parker presents findings from a phase 2 study on isatuximab for AL…